Literature DB >> 24239270

Root cause analysis of non-infectious transfusion complications and the lessons learnt.

Farheen Karim1, Bushra Moiz2, Naseem Shamsuddin1, Safia Naz1, Mohammad Khurshid1.   

Abstract

BACKGROUND: Transfusion of blood and blood products can be associated with hazards which may be at times fatal. Timely reporting of transfusion reactions is imperative for root cause analysis and their prevention in future.
METHODS: We retrospectively reviewed the transfusion reactions at our institution during last seven years. The data was retrieved from our computerized blood bank information system and by reviewing the medical charts of patients. The frequency of adverse effects, implicated products, wrong blood transfusion and its outcome were observed. RESULTS AND
CONCLUSIONS: During study period (2006-2012), a total of 393,662 blood or blood products were transfused. There were 458 adverse events with an estimated rate of 1.16 per 1000 blood products administered. During 2011-2012, 121 transfusion reactions were reported of 119,921 transfused units. The most common adverse effects were allergic reactions (70 episodes of 121 or 57.8%) followed by febrile non hemolytic transfusion reactions or FNHTR (43 events of 121 or 35.5%). Transfusion associated dyspnea, circulatory overload and transfusion associated lung injury were less frequent. During the study period, 142,066 red cell units were transfused with nine recognized ABO-mismatch transfusions and two fatalities. The computed incidence of ABO-mismatch transfusion was 1 in 15,785 with a mortality rate of 1 in 71,033 units transfused. Etiology included: errors in final bed side check (n=5), blood bank clerical errors (n=3) and mislabeled tube (n=1). A review of these cases prompted hospital transfusion committee for re-enforcing policies and protocols to minimize accidental ABO incompatible transfusions. We concluded that urticaria and FNHTR are the most frequent transfusion reactions in our setting. ABO mismatched blood transfusions are rare but preventable errors and result mainly from clerical imprecisions.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adverse effects; Blood transfusion; Non-infectious complications; Root cause analysis

Mesh:

Substances:

Year:  2013        PMID: 24239270     DOI: 10.1016/j.transci.2013.10.004

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  4 in total

1.  Molecular immunohaematology round table discussions at the AABB Annual Meeting, Philadelphia 2014.

Authors:  Willy A Flegel; Shirley L De Castilho; Margaret A Keller; Ellen B Klapper; Joann M Moulds; France Noizat-Pirenne; Nadine Shehata; Gary Stack; Maryse St-Louis; Christopher A Tormey; Dan A Waxman; Christof Weinstock; Silvano Wendel; Gregory A Denomme
Journal:  Blood Transfus       Date:  2015-12-21       Impact factor: 3.443

2.  Active Hemovigilance Significantly Improves Reporting of Acute Non-infectious Adverse Reactions to Blood Transfusion.

Authors:  Naveen Agnihotri; Ajju Agnihotri
Journal:  Indian J Hematol Blood Transfus       Date:  2015-07-16       Impact factor: 0.900

Review 3.  Improving platelet transfusion safety: biomedical and technical considerations.

Authors:  Olivier Garraud; Fabrice Cognasse; Jean-Daniel Tissot; Patricia Chavarin; Syria Laperche; Pascal Morel; Jean-Jacques Lefrère; Bruno Pozzetto; Miguel Lozano; Neil Blumberg; Jean-Claude Osselaer
Journal:  Blood Transfus       Date:  2015-11-16       Impact factor: 3.443

4.  Steps taken to alleviate under-reporting of transfusion reactions at a public sector hospital in Pakistan.

Authors:  Anila Rashid; Mohammad Akbar Agha; Saima Minhas; Bipin Nepal; Nadeem Nusrat
Journal:  Blood Res       Date:  2016-12-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.